Successful treatment of subcutaneous Purpureocillium lilacinum infection with fosravuconazole
The Journal of Dermatology · 2023-03 · 50 (3)
DOI: 10.1111/1346-8138.16631 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journal of Dermatology, online erschienen am 07.11.2022. Verfasst von Haruka Uehara und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of the Ryukyus Graduate School of Medicine, Okinawa, Japan. Hauptthemen laut MEDLINE: Hypocreales. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University of the Ryukyus Graduate School of Medicine, Okinawa, Japan.
ORCID-Profile: Sayaka Yamaguchi
Zitieren
APA
Uehara, H., Yamaguchi, S., Komatsu, K., Miyagi, T., & Takahashi, K. (2023). Successful treatment of subcutaneous Purpureocillium lilacinum infection with fosravuconazole. The Journal of Dermatology, 50(3). https://doi.org/10.1111/1346-8138.16631
Vancouver
Uehara H, Yamaguchi S, Komatsu K, Miyagi T, Takahashi K. Successful treatment of subcutaneous Purpureocillium lilacinum infection with fosravuconazole. The Journal of Dermatology. 2023;50(3). doi:10.1111/1346-8138.16631
BibTeX
@article{Uehara2023,
author = {Uehara, Haruka and Yamaguchi, Sayaka and Komatsu, Kotaro and Miyagi, Takuya and Takahashi, Kenzo},
title = {Successful treatment of subcutaneous Purpureocillium lilacinum infection with fosravuconazole},
journal = {The Journal of Dermatology},
year = {2023},
volume = {50},
number = {3},
doi = {10.1111/1346-8138.16631}
}
EUVIMED